By Paul Hodgson2016-06-21T12:00:00
A report from Her Majesty’s Crown Prosecution Service Inspectorate has attacked the Serious Fraud Office for being a largely white, all-male board. Paul Hodgson examines the merits of the report and the SFO’s response.
2016-09-20T12:30:00Z By Neil Hodge
Five years after the Bribery Act, the Serious Fraud Office has yet to produce a major conviction. Will Airbus—the latest aerospace company under investigation—be its first big collar? Neil Hodge reports.
2025-12-05T21:00:00Z By Pekka Alasaari and Johanna Schüßler, CW guest columnists
The European manufacturing industry is on the cusp of a regulatory shift that promises to reshape how machines are designed and operated.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud